Vitrolife AB Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Vitrolife AB

Vitrolife AB | Ownership

Companies that own Vitrolife AB

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Capital Research & Management Co. (World Investors)

5,002,795

4.61%

168,000

0.01%

06/30/2018

Lannebo Fonder AB

3,125,095

2.88%

1,395,280

0.75%

12/29/2017

Morgan Stanley Asia Ltd. (Investment Management)

2,744,878

2.52%

1,165,150

0.66%

07/31/2018

SEB Investment Management AB

2,509,625

2.31%

-1,278,310

0.1%

12/29/2017

Norges Bank Investment Management

2,153,675

1.98%

2,153,675

12/29/2017

Financière de l'Échiquier SA

1,845,715

1.7%

1,170,715

0.46%

03/29/2018

The Vanguard Group, Inc.

1,575,283

1.45%

6,510

07/31/2018

GLG Partners UK Ltd.

1,191,055

1.1%

0.24%

07/31/2018

Fjärde AP-fonden

930,100

0.86%

930,100

0.07%

12/31/2016

E. Öhman J :or Fonder AB

894,515

0.82%

8,410

0.27%

12/31/2017

About Vitrolife AB

View Profile

Address	Gustaf Werners Gata 2 Gothenburg VG 421 32 Sweden
Employees	-
Website	http://www.vitrolife.com
Updated	07/08/2019
Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. It operates through the following geographical segments: EMEA, North and South America, and Asia & Pacific. Its products include FertiRoof, Vitrification, Slow freezing, OVOIL-culture oil, and Follicle aspiration needles.